These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 24900664)
1. High-Throughput Selectivity Assays for Small-Molecule Inhibitors of β-Catenin/T-Cell Factor Protein-Protein Interactions. Zhang M; Catrow JL; Ji H ACS Med Chem Lett; 2013 Feb; 4(2):306-11. PubMed ID: 24900664 [TBL] [Abstract][Full Text] [Related]
2. Targeting the Tcf4 G13ANDE17 binding site to selectively disrupt β-catenin/T-cell factor protein-protein interactions. Huang Z; Zhang M; Burton SD; Katsakhyan LN; Ji H ACS Chem Biol; 2014 Jan; 9(1):193-201. PubMed ID: 24191653 [TBL] [Abstract][Full Text] [Related]
3. New homogeneous high-throughput assays for inhibitors of β-catenin/Tcf protein-protein interactions. Zhang M; Huang Z; Yu B; Ji H Anal Biochem; 2012 May; 424(1):57-63. PubMed ID: 22370279 [TBL] [Abstract][Full Text] [Related]
4. Optimization of Peptidomimetics as Selective Inhibitors for the β-Catenin/T-Cell Factor Protein-Protein Interaction. Wang Z; Zhang M; Wang J; Ji H J Med Chem; 2019 Apr; 62(7):3617-3635. PubMed ID: 30856332 [TBL] [Abstract][Full Text] [Related]
5. AlphaScreen selectivity assay for β-catenin/B-cell lymphoma 9 inhibitors. Zhang M; Wisniewski JA; Ji H Anal Biochem; 2015 Jan; 469():43-53. PubMed ID: 25312469 [TBL] [Abstract][Full Text] [Related]
6. Discovery of Selective Small-Molecule Inhibitors for the β-Catenin/T-Cell Factor Protein-Protein Interaction through the Optimization of the Acyl Hydrazone Moiety. Catrow JL; Zhang Y; Zhang M; Ji H J Med Chem; 2015 Jun; 58(11):4678-92. PubMed ID: 25985283 [TBL] [Abstract][Full Text] [Related]
7. Activator protein 2alpha associates with adenomatous polyposis coli/beta-catenin and Inhibits beta-catenin/T-cell factor transcriptional activity in colorectal cancer cells. Li Q; Dashwood RH J Biol Chem; 2004 Oct; 279(44):45669-75. PubMed ID: 15331612 [TBL] [Abstract][Full Text] [Related]
8. Inhibition of integrin linked kinase (ILK) suppresses beta-catenin-Lef/Tcf-dependent transcription and expression of the E-cadherin repressor, snail, in APC-/- human colon carcinoma cells. Tan C; Costello P; Sanghera J; Dominguez D; Baulida J; de Herreros AG; Dedhar S Oncogene; 2001 Jan; 20(1):133-40. PubMed ID: 11244511 [TBL] [Abstract][Full Text] [Related]
9. The Yin-Yang of TCF/beta-catenin signaling. Barker N; Morin PJ; Clevers H Adv Cancer Res; 2000; 77():1-24. PubMed ID: 10549354 [TBL] [Abstract][Full Text] [Related]
10. Beta- and gamma-catenin mutations, but not E-cadherin inactivation, underlie T-cell factor/lymphoid enhancer factor transcriptional deregulation in gastric and pancreatic cancer. Caca K; Kolligs FT; Ji X; Hayes M; Qian J; Yahanda A; Rimm DL; Costa J; Fearon ER Cell Growth Differ; 1999 Jun; 10(6):369-76. PubMed ID: 10392898 [TBL] [Abstract][Full Text] [Related]
11. Rational design of small-molecule inhibitors for β-catenin/T-cell factor protein-protein interactions by bioisostere replacement. Yu B; Huang Z; Zhang M; Dillard DR; Ji H ACS Chem Biol; 2013 Mar; 8(3):524-9. PubMed ID: 23272635 [TBL] [Abstract][Full Text] [Related]
12. The Wnt/β-catenin/T-cell factor 4 pathway up-regulates high-mobility group A1 expression in colon cancer. Bush BM; Brock AT; Deng JA; Nelson RA; Sumter TF Cell Biochem Funct; 2013 Apr; 31(3):228-36. PubMed ID: 22961697 [TBL] [Abstract][Full Text] [Related]
13. Multiple roles of Adenomatous Polyposis Coli gene in Wnt Signalling - a Computational Model. Raji RJ; Sasikumar R; Jacob E Biosystems; 2018 Oct; 172():26-36. PubMed ID: 30110600 [TBL] [Abstract][Full Text] [Related]
14. Tissue-Specific Effects of Reduced β-catenin Expression on Adenomatous Polyposis Coli Mutation-Instigated Tumorigenesis in Mouse Colon and Ovarian Epithelium. Feng Y; Sakamoto N; Wu R; Liu JY; Wiese A; Green ME; Green M; Akyol A; Roy BC; Zhai Y; Cho KR; Fearon ER PLoS Genet; 2015 Nov; 11(11):e1005638. PubMed ID: 26528816 [TBL] [Abstract][Full Text] [Related]
15. Thermodynamics of beta-catenin-ligand interactions: the roles of the N- and C-terminal tails in modulating binding affinity. Choi HJ; Huber AH; Weis WI J Biol Chem; 2006 Jan; 281(2):1027-38. PubMed ID: 16293619 [TBL] [Abstract][Full Text] [Related]
16. Systematic peptide array-based delineation of the differential beta-catenin interaction with Tcf4, E-cadherin, and adenomatous polyposis coli. Gail R; Frank R; Wittinghofer A J Biol Chem; 2005 Feb; 280(8):7107-17. PubMed ID: 15591320 [TBL] [Abstract][Full Text] [Related]
17. Extracellular inhibitors can attenuate tumorigenic Wnt pathway activity in adenomatous polyposis coli mutants: Predictions of a validated mathematical model. Hochman G; Halevi-Tobias K; Kogan Y; Agur Z PLoS One; 2017; 12(7):e0179888. PubMed ID: 28708837 [TBL] [Abstract][Full Text] [Related]
18. Nucleo-cytoplasmic shuttling of APC can maximize β-catenin/TCF concentration. Schmitz Y; Wolkenhauer O; Rateitschak K J Theor Biol; 2011 Jun; 279(1):132-42. PubMed ID: 21439299 [TBL] [Abstract][Full Text] [Related]
19. A possible role for the WNT-1 pathway in oral carcinogenesis. Lo Muzio L Crit Rev Oral Biol Med; 2001; 12(2):152-65. PubMed ID: 11345525 [TBL] [Abstract][Full Text] [Related]
20. Role for ICAT in beta-catenin-dependent nuclear signaling and cadherin functions. Gottardi CJ; Gumbiner BM Am J Physiol Cell Physiol; 2004 Apr; 286(4):C747-56. PubMed ID: 14613891 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]